Methods of treating arthritis and diabetic retinopathy with .alpha..sub.v.beta..sub.3-specific antibodies
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Apr 8, 2008
Grant Date -
Jan 6, 2005
app pub date -
Jul 15, 2004
filing date -
Mar 18, 1994
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The present invention describes methods for inhibition angiogenesis in tissues using vitronectin .alpha..sub.v.beta..sub.3 antagonists, and particularly for inhibiting angiogenesis in inflamed tissues and in tumor tissues and metastases using therapeutic compositions containing .alpha..sub.v.beta..sub.3 antagonists.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully